Corpus ID: 55682345

The Three C ’ s of Antibiotic Allergy – Classification , Cross-Reactivity and Collaboration

  title={The Three C ’ s of Antibiotic Allergy – Classification , Cross-Reactivity and Collaboration},
  author={Jason A. Trubiano and Cosby A Stone and Lindsay M. Grayson and Karen and Urbancic and Bpharm and Monica A. Slavin and Karin A. Thursky and J. Elizabeth and Phillips},
Antibiotic allergy labelling is highly prevalent and negatively impacts patient outcomes and antibiotic appropriateness. Reducing the prevalence and burden of antibiotic allergies requires the engagement of key stakeholders such as allergists, immunologists, pharmacists and infectious diseases physicians. To help address this burden of antibiotic allergy over-labelling, we review three key antibiotic allergy domains: (a) antibiotic allergy classification, (b) antibiotic crossreactivity and (c… Expand

Figures from this paper

Antibiotic allergy labels—the impact of taking a clinical history
Many patients admitted to hospital have an antibiotic allergy (AAL) documented in their medical record, but the reaction is not a hypersensitivity reaction or may no longer be relevant, and the label adversely affects patient care and the development of antimicrobial resistance. Expand
Antimicrobial Desensitization: A Review of Published Protocols
The purpose of this review is to provide a greater insight for clinicians and institutions to ensure desensitization procedures are efficacious while minimizing potential for patient harm. Expand


Antimicrobial stewardship's new weapon? A review of antibiotic allergy and pathways to 'de-labeling'.
More recent literature supports that appropriate antibiotic allergy in-vitro and in- vivo testing and subsequent antibiotic allergy de-labeling can decrease broad-spectrum antibiotic use, costs, patient length of stay, and mortality. Expand
The prevalence and impact of antimicrobial allergies and adverse drug reactions at an Australian tertiary centre
In an Australian tertiary referral centre an antimicrobial “allergy” or ADR label was found to significantly impacted on rate of oral antimicrobial administration, beta-lactam usage, antimicrobial duration and antimicrobial appropriateness. Expand
Identifying opportunities in EHR to improve the quality of antibiotic allergy data
Improved EHR documentation guidance, training that reinforces the use of standardized data and more detailed recording of allergic reactions, combined with initiatives to address patient barriers including health literacy, may help to improve the accuracy of drug allergies in patients' records. Expand
Practical Management of Antibiotic Hypersensitivity in 2017.
Skin testing and direct challenges are the primary tools used to determine acute tolerance in 2017 and commercially available in vitro testing is not currently clinically useful in determining antibiotic hypersensitivity, with rare exceptions. Expand
Impact of an Integrated Antibiotic Allergy Testing Program on Antimicrobial Stewardship: A Multicenter Evaluation
An integrated AAT-AMS program was effective in both de-labeling of AALs and promotion of improved antibiotic usage and appropriateness, supporting the routine incorporation of AAT into AMS programs. Expand
The incidence of antimicrobial allergies in hospitalized patients: implications regarding prescribing patterns and emerging bacterial resistance.
The incidence of penicillin allergy at the authors' institution exceeds population averages, and this finding, in combination with limited documentation of drug allergies, appears to lead to the prescribing of alternative antimicrobial agents that do not fit into institutional antimicrobial guidelines and, in some instances, may put the patient at risk for infection and/or colonization with resistant organisms. Expand
The impact of antimicrobial allergy labels on antimicrobial usage in cancer patients
Patients in the AA group on multivariate analysis had a higher number of antibiotics employed, longer duration of antibiotic therapy and higher rate of readmission, suggesting antimicrobial usage, including the use of restricted antibiotics, is higher in patients with cancer. Expand
Collaboration between Allergists and Pharmacists Increases β-Lactam Antibiotic Prescriptions in Patients with a History of Penicillin Allergy
A collaborative effort between allergists and pharmacists can increase β-lactam antibiotic prescriptions and decrease non-β- lactam prescriptions in patients with a history of penicillin allergy. Expand
Adverse reactions to β-lactam antimicrobials
A literature review was undertaken using PubMed, focusing primarily on literature published in the past 10 years relating to β-lactam adverse events and allergy, focusing on recognition, diagnosis and management of true allergy and risk of cross-sensitivity between β- lactam antibiotics. Expand
Improving Clinical Outcomes in Patients With Methicillin-Sensitive Staphylococcus aureus Bacteremia and Reported Penicillin Allergy.
Patients with MSSA bacteremia and a reported PCN allergy should have the allergy addressed for optimal treatment, and full allergy evaluation with skin testing seems to be preferred, although more data are needed. Expand